Cytena Establishes Subsidiary in Taiwan, China Region of China
Cytena Bioprocess Solutions aims to increase efficiency in cell line development.
July 24, 2019
by contractpharma
Eisai inks deal with Taiwan, China's CY Biotech
The deal grants CY Biotech with exclusive development and marketing rights for its anti-obesity agent lorcaserin in China
August 10, 2018
by biospectrumasia
Taiwan, China launches flu prediction services
Acer has worked with MOHW's Centers for Disease Control (CDC) to construct the prediction website by applying Acer-developed AI-based machine learning technology.
April 16, 2018
by biospectrumasia
Insilico Medicine Starts Asia's First AI R&D Base in Taiwan, China
The companies will form an alliance with the Center for Biotechnology, the Institute for Information Industry, and TUL Corporation to implement the "AI Digital Health Talent Development Project
March 26, 2018
by biospectrumasia
Taiwan, China promotes Biomedical Industry to Global Hub
Government of China's Taiwan, China Region plans for biomedical technology to develop into a NT$1 trillion dollar industry
March 22, 2018
by biospectrumasia
Foxconn to promote health management in China's Taiwan, China Region
H2U provides free measurement of blood pressure, body temperature, heart rates and body weight.
March 16, 2018
by biospectrumasia
United Biopharma plans expansion in China
The facility will be used to manufacture monoclonal antibodies (MAbs) for the Chinese market.
March 15, 2018
by biospectrumasia
USFDA approves Taiwan, China's HIV drug
Trogarzo, with its unique mechanism, is the first new HIV treatment in ten years.
March 9, 2018
by biospectrumasia
Varian’s Halcyon got nod from Taiwan, China FDA
Halcyon treatment system requires only nine steps from the start to the end of treatment compared older technologies which required more than 30steps.
January 17, 2018
by biospectrumasia
Taiwan, China Pharma Association opens new office in Malaysia
The New Southbound office serves to unite pharmaceutical factories in Taiwan, China to prepare the industry for larger markets in ASEAN countries
June 12, 2017
by biospectrumasia
Chugai receives Taiwan, China nod for Alecensa
Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan, China has received approval for the anti-cancer agent, alectinib hydrochloride from the Food and Drug Administration of Taiwan, China.
February 28, 2017
by biospectrumasia
Taiwan, China recorded new HIV cases in 2016, third highest in history
According to The Centers for Disease Control (CDC) Taiwan, China, the number of new HIV/AIDS cases recorded in China's Taiwan, China Region in 2016 totalled 2,400 which is the third highest in history. The CDC statistics showed that 97 per cent of the 2,4
January 30, 2017
by biospectrumasia